Emory Mctyre
Experienced in Neuralgia

Dr. Emory Mctyre

Radiation Oncology
Prisma Health
Prisma Health Cancer Institute – Faris Rd.
900 West Faris Road, 
Greenville, SC 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients

Experienced in Neuralgia
Prisma Health
Prisma Health Cancer Institute – Faris Rd.
900 West Faris Road, 
Greenville, SC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Emory Mctyre is a Radiation Oncologist in Greenville, South Carolina. Dr. Mctyre is rated as an Experienced provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Gamma Knife Radiosurgery. Dr. Mctyre is currently accepting new patients.

His clinical research consists of co-authoring 47 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Mercer University
Residency
Wake Forest University Baptist Medical Center
Specialties
Radiation Oncology
Licenses
Radiology in SC
Board Certifications
American Board Of Radiology
Hospital Affiliations
Prisma Health Greer Memorial Hospital
Prisma Health Greenville Memorial Hospital
Prisma Health Patewood Hospital
Prisma Health Baptist Easley Hospital
Prisma Health Hillcrest Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Prisma Health Cancer Institute – Faris Rd.
900 West Faris Road, Greenville, SC 29605
Call: 864-679-3900
Other Locations
Prisma Health Cancer Institute – Greer
340 Medical Parkway, Greer, SC 29650
Call: 864-662-4000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Procedure, Radiation, Drug
Study Drug: Atezolizumab
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 31, 2025
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 20, 2025
Intervention Type: Drug, Procedure, Radiation, Other
Study Drug: Olaparib
Study Phase: Phase 2
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2025
Intervention Type: Biological, Drug, Radiation
Study Drugs: Gonadotrophin releasing hormone, Niraparib
Study Phase: Phase 1/Phase 2
Phase III Trial of Stereotactic Radiosurgery (SRS) or Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Distant Brain Relapse With Brain Metastasis Velocity >/= 4 Brain Metastases/Year
Phase III Trial of Stereotactic Radiosurgery (SRS) or Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Distant Brain Relapse With Brain Metastasis Velocity >/= 4 Brain Metastases/Year
Enrollment Status: Terminated
Publish Date: June 06, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drug: Memantine
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials

47 Total Publications

Collagen deposition within brain metastases is associated with leptomeningeal failure after 
cavity-directed radiosurgery.
Collagen deposition within brain metastases is associated with leptomeningeal failure after 
cavity-directed radiosurgery.
Journal: Neuro-oncology advances
Published: February 15, 2023
View All 47 Publications
Similar Doctors
Michael P. Greenbaum
Advanced in Neuralgia
Dr. Michael P. Greenbaum
Radiation Oncology
Advanced in Neuralgia
Dr. Michael P. Greenbaum
Radiation Oncology

Prisma Health Cancer Institute – Eastside

65 International Drive, 
Greenville, SC 
 (5.6 miles away)
864-679-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Greenbaum is a Radiation Oncologist in Greenville, South Carolina. Dr. Greenbaum is rated as a Distinguished provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Posterior Fossa Tumor. Dr. Greenbaum is currently accepting new patients.

Experienced in Neuralgia
Dr. Matthew C. Hull
Radiation Oncology
Experienced in Neuralgia
Dr. Matthew C. Hull
Radiation Oncology

Mission Health Community Multispecialty Providers LLC

509 Biltmore Ave, 
Asheville, NC 
 (53.1 miles away)
828-213-2325
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Matthew Hull is a Radiation Oncologist in Asheville, North Carolina. Dr. Hull is rated as a Distinguished provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET). Dr. Hull is currently accepting new patients.

Experienced in Neuralgia
Dr. Daniel B. Fried
Radiation Oncology
Experienced in Neuralgia
Dr. Daniel B. Fried
Radiation Oncology

Spartanburg Medical Center

101 E Wood St, 
Spartanburg, SC 
 (28.6 miles away)
864-560-6917
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Fried is a Radiation Oncologist in Spartanburg, South Carolina. Dr. Fried is rated as a Distinguished provider by MediFind in the treatment of Neuralgia. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Astrocytoma, and Lung Cancer. Dr. Fried is currently accepting new patients.

VIEW MORE NEURALGIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mctyre's expertise for a condition
ConditionClose
    • Distinguished
    • Familial Prostate Cancer
      Dr. Mctyre is
      Distinguished
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    • Prostate Cancer
      Dr. Mctyre is
      Distinguished
      . Learn about Prostate Cancer.
      See more Prostate Cancer experts
    • Advanced
    • Brain Tumor
      Dr. Mctyre is
      Advanced
      . Learn about Brain Tumor.
      See more Brain Tumor experts
    • Breast Cancer
      Dr. Mctyre is
      Advanced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Pleuropulmonary Blastoma
      Dr. Mctyre is
      Advanced
      . Learn about Pleuropulmonary Blastoma.
      See more Pleuropulmonary Blastoma experts
    • Posterior Fossa Tumor
      Dr. Mctyre is
      Advanced
      . Learn about Posterior Fossa Tumor.
      See more Posterior Fossa Tumor experts
    • Primitive Neuroectodermal Tumor (PNET)
      Dr. Mctyre is
      Advanced
      . Learn about Primitive Neuroectodermal Tumor (PNET).
      See more Primitive Neuroectodermal Tumor (PNET) experts
    • Experienced
    • Acoustic Neuroma
      Dr. Mctyre is
      Experienced
      . Learn about Acoustic Neuroma.
      See more Acoustic Neuroma experts
    • Adult Soft Tissue Sarcoma
      Dr. Mctyre is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Mctyre is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anal Cancer
      Dr. Mctyre is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Astrocytoma
      Dr. Mctyre is
      Experienced
      . Learn about Astrocytoma.
      See more Astrocytoma experts
    • Atypical Teratoid Rhabdoid Tumor (ATRT)
      Dr. Mctyre is
      Experienced
      . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
      See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
    View All 41 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.